Price movement over the last 24 hours
Align Technology, Inc. vs Invesco DB Agriculture Fund — how do they compare? Align Technology, Inc. trades at $173.86 (market cap $13.27B), while Invesco DB Agriculture Fund trades at $27.62. Which is the better fit depends on your goals.
| ALGN | DBA | |
|---|---|---|
Market Cap | $13.27B | — |
Sector | Health | — |
52-Week High | $207.19 | $28.73 |
52-Week Low | $124.88 | $25.44 |
Enterprise Value | $12.32B | — |
Signals from Pluang's Aura AI — not financial advice
ALGN trades at $185.22, up 0.38% today, with a bullish technical signal and strong analyst consensus. The stock has consistently beaten earnings estimates in recent quarters, with Q2 2026 results expected soon. Revenue remains stable around $4.0B, supported by a 67.57% gross margin and positive cash flow trends. Recent news highlights global expansion and product innovation, including a new manufacturing facility in India.
Outlook is positive with a $220.75 consensus price target, though risks include regulatory scrutiny from the European Commission and competitive pressures. The stock's valuation at a P/E of 31.65 reflects growth expectations, but investors should monitor execution on international growth and demand stability in North America.
DBA (Invesco DB Agriculture Fund) trades at $27.54, up 2.99% with strong bullish technical signals from moving averages. The fund tracks agricultural commodities including corn, soybeans, and livestock futures. Recent news highlights supply disruptions in Brazil's coffee harvest and China's $17 billion crop purchase commitment through 2028, creating favorable conditions for agricultural ETFs.
The agricultural commodity rally presents upside potential, though overbought RSI readings suggest near-term consolidation. Key risks include weather volatility affecting crop yields and geopolitical impacts on global trade flows. The fund's diversified exposure offers hedging benefits against inflation but remains sensitive to commodity price swings.
Trailing returns across standard periods
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →The index, which is comprised of one or more underlying commodities ("index commodities"), is intended to reflect the agricultural sector. The fund pursues its investment objective by investing in a portfolio of exchange-traded futures.
Read more on DBA →